Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes
Clinical trial NCT02537470 · COMPLETED
Trial details
- NCT number
- NCT02537470
- Sponsor
- BHV Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-08-01
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.